- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$0.94 BnMarket Estimate, 2026
$1.05 BnMarket Forecast, 2034
$2.57 BnCAGR, 2026–2034
11.79%Executive Summary: Europe Precision Medicine Software Market
- Market Scope: Regional analysis of Europe's precision medicine software sector, detailing delivery modes, clinical applications, end-user frameworks, regulatory compliance, and country-level profiles.
- Market Valuation: Valued at USD 0.94 billion in 2025, reaching USD 1.05 billion in 2026, and projected to expand to USD 2.57 billion by 2034, growing at a robust CAGR of 11.79% from 2026 to 2034.
- Primary Growth Drivers: Integration of clinical and molecular data, growing prevalence and diagnosis of cancer, recent advancements in big data technology for accurate disease detection, and rising acceptance of gene therapy sequencing.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Delivery Mode | Web & Cloud-Based (dominated base year market share, driven by scalability, remote data access, and clinical workflow integration) | Web & Cloud-Based (projected at a rapid growth rate, fueled by big data analytics and secure cloud storage demands) |
| By Application | Oncology (accounted for the largest market share, backed by rising cancer diagnosis and targeted biomarker analysis) | Pharmacogenomics & Rare Diseases (registering highest growth, driven by advances in genetic sequencing and personalized drug discovery) |
| By End User | Healthcare Providers (captured major market share, supported by electronic medical records and clinical diagnostic usage) | Research Centers and Academic Institutes (projected at an extraordinary CAGR, propelled by genomic research and big data trials) |
| By Country | United Kingdom (market leader with dominant share, backed by high disposable income and advanced healthcare infrastructure) | Germany (experiencing strong growth at a 7.9% CAGR, driven by an aging geriatric population and rising chronic disease burden) |
Major Market Players & Industry Landscape
Market Structure: Highly competitive, technology-driven landscape characterized by specialized genomics software providers, healthcare technology leaders, and diagnostic platform developers integrating big data solutions.
Key Companies: SOPHiA GENETICS SA, Syapse, Inc., Foundation Medicine, Inc., 2bPrecise LLC, Fabric Genomics, Human Longevity, Inc., Translational Software, Inc., Gene42, Inc., IBM Watson Group, LifeOmic Health, LLC, Sunquest Information Systems Inc., Koninklijke Philips N.V., and Flatiron Health, Inc.
Download Free Sample Report
Europe Precision Medicine Software Market Size
The global ethylene market size was valued at USD 0.94 billion in 2025 and is anticipated to reach USD 1.05 billion in 2026 from USD 2.57 billion by 2034, growing at a CAGR of 11.79% during the forecast period from 2026 to 2034.
The emergence of precision medicine has responded to the pressing need for better diagnostic and analytical tools. Precision medicine software combines clinical and molecular data to provide valuable information for determining the ideal treatment.
The increased use of complex biomarkers, growing prevalence, and diagnosis of cancer are expected to drive the growth of the precision medicine software market in the European region. In addition, the market has also been introduced to improve clinical workflow. It will increase the likelihood that large amounts of genetic information will be stored to ensure the rapid recovery of patients, which may drive the growth of the precision medicine software market in this region.
Recent advancements in the applications of big data technology for accurate disease detection will positively impact the market share during the forecast period. Additionally, introducing software with improved clinical workflow will likely increase the capacity to store a large amount of genetic data to ensure rapid patient recovery. This, in turn, will drive the growth of the precision medicine software market in the years to come. In addition, software specially designed to develop precision drugs used in the treatment of chronic diseases and genetic diseases that ensure rapid recovery of patients will increase the size of the market in the years to come. The growing acceptance of big data analysis and gene therapy gene sequencing will increase market growth in the near future.
Factors such as concerns about data privacy, data thefts, and the need to comply with regulatory requirements while working with patient data are limiting the market growth. Additionally, the high cost of implementation, lack of reimbursement for precision drug treatments, and the need for highly skilled IT professionals for the highly complex data associated with precision medicine software are limiting the growth of the European precision medicine software market.
The European region has better diagnostic tools, medicines, and electronic medical records, which is expected to provide lucrative opportunities for market growth in the future. In the European region, the United Kingdom precision medicine software market is expected to lead during the forecast period due to the higher disposable income and better healthcare infrastructure become available.
In Europe, the German precision medicine software market is expected to grow at a CAGR of around 7.9% during the forecast period. The German market is expected to experience strong growth during the forecast period. This growth can be attributed to the increase in the geriatric population suffering from chronic diseases like cancer. This precision medicine software market is expected to grow in the coming years. In addition, the growing burden of genetic diseases in the Netherlands will drive demand for gene therapies in the European region.
KEY MARKET PLAYERS
Some of the prominent companies operating in the European precision medicine software market include
- SOPHiA GENETICS SA
- Syapse, Inc.
- Foundation Medicine, Inc.
- 2bPrecise LLC
- Fabric Genomics
- Human Longevity, Inc.
- Translational Software, Inc.
- Gene42, Inc.
- IBM Watson Group
- LifeOmic Health, LLC
- Sunquest Information Systems Inc.
- Koninklijke Philips N.V.
- Flatiron Health, Inc.
MARKET SEGMENTATION
This research report on the European precision medicine software market has been segmented and sub-segmented into the following categories.
By Delivery Mode
- Web & Cloud-Based
- On-Premise
By Application
- Oncology
- Pharmacogenomics
- Rare Diseases
- Other Applications
By End User
- Healthcare Providers
- Research Centers and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Other End Users
By Country
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe